Marksans Pharma Market Cap

Marksans Pharma has a market cap or net worth of 105.67 billion as of June 5, 2026. Its market cap has decreased by -3.40% in one year.

Market Cap

105.67B

Enterprise Value

99.51B

Revenue

29.51B

Ranking

n/a

PE Ratio

25.29

Stock Price

233.50

Market Cap Chart

Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 105.67B, an increase of 2,793.92%. That is a compound annual growth rate of 18.85%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2026	105.67B	29.34%
Dec 31, 2025	81.70B	-39.22%
Dec 31, 2024	134.43B	84.14%
Dec 29, 2023	73.00B	210.96%
Dec 30, 2022	23.48B	-4.66%
Dec 31, 2021	24.63B	-0.80%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4.28T
Divi's Laboratories	1.76T
Apollo Hospitals Enterprise	1.19T
Cipla	1.13T
Indegene	125.52B
Park Medi World	121.70B
Metropolis Healthcare	110.55B
Sanofi Consumer Healthcare India	109.76B

Market Cap Rankings